Kidtro Eye Drop contains Atropine 0.01% w/v, a muscarinic antagonist used primarily in ophthalmic practice to induce mydriasis and cycloplegia. Atropine acts by inhibiting the parasympathetic innervation of the iris sphincter and ciliary muscles, resulting in pupil dilation and paralysis of accommodation. Kidtro Eye Drop is indicated for the management of myopia progression in pediatric patients, as low-dose atropine has been shown to slow axial elongation of the eye. It is also employed in diagnostic procedures requiring pupil dilation and in the treatment of certain inflammatory conditions of the anterior segment of the eye. The 0.01% concentration offers a favorable safety profile with minimal side effects compared to higher doses, reducing the risk of photophobia and blurred near vision. Administration should be performed under ophthalmologic supervision, with caution in patients with a history of hypersensitivity to atropine or related compounds. Contraindications include narrow-angle glaucoma and known hypersensitivity. Common adverse effects may include mild ocular irritation, dryness, or transient blurred vision. Patients are advised to avoid exposure to bright light following instillation and to report any severe or persistent symptoms to their healthcare provider promptly. Kidtro Eye Drop should be stored at controlled room temperature and kept out of reach of children.